|
Board of Directors
- James
C. Mullen
Chairman and Chief Executive Officer, Biogen Inc.
- Alan Belzer
President, Chief Operating Officer and Director, Allied-Signal,
Inc. (retired)
- Lawrence C. Best
Senior Vice President and Chief Financial Officer, Boston Scientific
- Thomas F. Keller, Ph.D.
R.J. Reynolds Professor and Former Dean, Fuqua School of Business,
Duke University
- Mary L. Good, Ph.D.
Former Undersecretary for Technology, U.S. Department of Commerce
- Roger H. Morley
Vice President, Schiller International University
- Sir Kenneth Murray, Ph.D.
Biogen Professor of Molecular Biology, University of Edinburgh;
Fellow of The Royal Society
- Eckhard Pfeiffer
Former Compaq President and Chief Executive Officer
- Phillip A. Sharp, Ph.D.
Director of the McGovern Institute for Brain Research, Massachusetts
Institute of Technology; Nobel Laureate
- Alan K. Simpson
Visiting Lecturer, University of Wyoming
- James W. Stevens
Former Chairman, Prudential Asset Management Group
Lawrence C. Best
Senior Vice President and Chief Financial Officer, Boston Scientific
Director since February 2003. Senior Vice President and Chief Financial Officer for Boston Scientific since 1992. Prior to his work with Boston Scientific, Mr. Best was a partner in the accounting firm of Ernst & Young, where he specialized in serving multinational companies in the high technology and life sciences fields. He served a two-year fellowship at the Securities & Exchange Commission from 1979 to 1981 and a one-year term as a White House-appointed Presidential Exchange Executive in Washington, D.C.
|
|
